NCT06539780
Imagery Rescripting as a Treatment for Early Psychosis
StatusCompleted
PhaseNot applicable
Primary completion
Track this trial
Free. We email you which fields changed when ClinicalTrials.gov updates this record.
Record History
All 4 versions: 4 with changes below. See every version on ClinicalTrials.gov ↗
Notable Primary endpoint(s) modified Show 6 more changesShow less
- Eligibility criteria expanded, about 7 words
- Trial completed
- Final enrollment: 4 participants (planned 8)
- Study completion date changed from estimate of Feb 2026 to Dec 16, 2025
- Primary completion date changed from estimate of Dec 2025 to Nov 20, 2025
- Secondary endpoints: details revised at 3 of 5 entries
Notable Start date: Feb 23, 2024 to Dec 20, 2024v3 Show 4 more changesShow less
- Trial status: Recruiting to Active, Not Recruiting
- Primary completion date: Jun 2025 to Dec 2025
- Study completion date: Jan 2026 to Feb 2026
- Site details revised
- Minor Secondary endpoints: details revised at 3 of 5 entriesv2
- Study First Submitted
- Notable: the plan changed
- Minor: routine updates
Endpoints
Primary
Schema or core beliefs
Timeframe: 7-9 weeks
Wellbeing
Timeframe: 4 times: at start, end baseline (up to 3 weeks), after treatment (expected 3 weeks after start of intervention), at follow up (3 weeks after ending treatment)
Self Esteem
Timeframe: 4 times: at start, end baseline (up to 3 weeks), after treatment (expected 3 weeks after start of intervention), at follow up (3 weeks after ending treatment)
Psychotic symptoms
Timeframe: 7-9 weeks
Secondary (5)
Psychotic symptoms
Trauma Symptoms
Strength of affect
Obtrusiveness of image
Emotions
Arms and interventions
Imagery RescriptingExperimental
Baseline consists of a random assigned period of 1-3 weeks with measurements and no intervention. Intervention consists of a maximum of 6 sessions of imagery rescripting, provided twice-weekly. Post treatment follow up consists of 3 weeks with only measurements and no intervention.
Behavioral: Imagery Rescripting
Sites
1 site in 1 country
- Amsterdam UMCAmsterdam-Zuidoost, North Holland, Netherlands